Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00706615 | Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer | withdrawn | Phase 1 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 31, 2020 | clinicaltrials |
| NCT00999557 | Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 31, 2020 |
| clinicaltrials |
| NCT03393117 | Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jul 22, 2020 | clinicaltrials |
| NCT02547961 | Chimeric Antigen Receptor-Modified T Cells for Breast Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT04088032 | Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer | withdrawn | Early Phase 1 | 0 | Alison StopeckOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT04149444 | A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast Cancer(TACTIC) | withdrawn | Phase 2 | 0 | AHS Cancer Control AlbertaOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT02748746 | Early Detection of Lymphedema With Bio-Electrical Impedance Analysis in Patients After Breast Cancer Surgery(BIA) | withdrawn | N/A | 0 | Abant Izzet Baysal UniversityOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04332549 | To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer | withdrawn | Phase 1 | 0 | Sun Pharma Advanced Research Company LimitedINDUSTRY | 1 | Jun 1, 2020 | clinicaltrials |
| NCT03065712 | Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET | withdrawn | Phase 2 | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT03637868 | Eribulin in Brain Metastases From HER2-negative Breast Cancer(ERIBRAIN) | withdrawn | Phase 2 | 0 | Institut Paoli-CalmettesOTHER | 1 | May 6, 2020 | clinicaltrials |
| NCT03400254 | Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")(GLACIER) | withdrawn | Phase 1 / Phase 2 | 0 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT03176888 | Health Benefits of HIT for Breast Cancer Patients | withdrawn | N/A | 0 | University of StirlingOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT02713984 | A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Zhi YangOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT02619669 | Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer | withdrawn | Phase 1 | 0 | Gary SchwartzOTHER | 1 | Mar 12, 2020 | clinicaltrials |
| NCT03721211 | Imaging With [11C]Martinostat in Breast Cancer | withdrawn | Phase 1 | 0 | Christine Elizabeth EdmondsOTHER | 1 | Mar 3, 2020 | clinicaltrials |
| NCT03110445 | Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus(rVV-740CTA) | withdrawn | Phase 1 | 0 | University Hospital, Basel, SwitzerlandOTHER | 0 | Feb 7, 2020 | clinicaltrials |
| NCT03323424 | Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers(IRAM) | withdrawn | Phase 2 | 0 | Institut de Cancérologie de la LoireOTHER | 1 | Jan 30, 2020 | clinicaltrials |
| NCT02018419 | Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients(MBC) | withdrawn | Phase 1 / Phase 2 | 0 | Mirror Biologics, Inc.INDUSTRY | 1 | Jan 22, 2020 | clinicaltrials |
| NCT03611985 | Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients | withdrawn | Phase 1 / Phase 2 | 0 | University of FloridaOTHER | 0 | Jan 13, 2020 | clinicaltrials |
| NCT03811418 | A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer(ATTILA) | withdrawn | Phase 3 | 0 | iOMEDICO AGINDUSTRY | 1 | Nov 26, 2019 | clinicaltrials |
| NCT02853071 | Efficacy and Safety of Estracyt® in Metastatic Breast Cancer(BEST) | withdrawn | Phase 2 | 0 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT01679743 | GRN1005 for Brain Metastases From Breast or Lung Cancer | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Nov 15, 2019 | clinicaltrials |
| NCT03185871 | Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses | withdrawn | Phase 2 | 0 | University of Wisconsin, MadisonOTHER | 0 | Nov 15, 2019 | clinicaltrials |
| NCT03340402 | Preoperative Accelerated Partial Breast Irradiation for Triple Negative Breast Cancer Using Proton Beam Scanning | withdrawn | N/A | 0 | Massachusetts General HospitalOTHER | 1 | Nov 14, 2019 | clinicaltrials |
| NCT02538432 | Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors | withdrawn | Phase 2 | 0 | University of Maryland, BaltimoreOTHER | 0 | Nov 4, 2019 | clinicaltrials |
| NCT03091842 | Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 1 | Oct 24, 2019 | clinicaltrials |
| NCT00329017 | Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer | withdrawn | — | 0 | Carol Fabian, MDOTHER | 1 | Oct 10, 2019 | clinicaltrials |
| NCT03408561 | Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT03988114 | A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer(proMONARCH) | withdrawn | Phase 4 | 0 | Eli Lilly and CompanyINDUSTRY | 9 | Sep 6, 2019 | clinicaltrials |
| NCT03523299 | Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer | withdrawn | N/A | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 0 | Aug 21, 2019 | clinicaltrials |
| NCT02190539 | Homeopathic Protocol for Advanced Breast Cancer | withdrawn | N/A | 0 | Meir Medical CenterOTHER | 1 | Aug 14, 2019 | clinicaltrials |
| NCT03918317 | A Study of the Use of AirXpanders AeroForm in Patients Undergoing Post-Mastectomy Radiation Therapy | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Aug 13, 2019 | clinicaltrials |
| NCT03794596 | A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer(IMpALA) | withdrawn | Phase 2 | 0 | The Christie NHS Foundation TrustOTHER | 0 | Jul 22, 2019 | clinicaltrials |
| NCT00960544 | Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jun 14, 2019 | clinicaltrials |
| NCT02817607 | Study to Assess Breast Sensation Before and After Breast Cancer Treatment | withdrawn | N/A | 0 | Duke UniversityOTHER | 1 | May 7, 2019 | clinicaltrials |
| NCT03644589 | Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer | withdrawn | Phase 2 | 0 | University of WashingtonOTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT03158441 | DTi Diffusion Findings in Breast MRI Screening and Diagnostic | withdrawn | — | 0 | Rabin Medical CenterOTHER | 0 | Apr 23, 2019 | clinicaltrials |
| NCT03058939 | Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer | withdrawn | Phase 2 | 0 | University of ChicagoOTHER | 1 | Apr 22, 2019 | clinicaltrials |
| NCT02324894 | Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound. | withdrawn | N/A | 0 | Brugmann University HospitalOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT02610920 | Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection | withdrawn | Early Phase 1 | 0 | Columbia UniversityOTHER | 0 | Mar 26, 2019 | clinicaltrials |
| NCT02574546 | Markers for Predicting Risk of Breast Cancer in Women of Different Races | withdrawn | — | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT03127332 | Metastatic Breast Cancer Treatment Planning | withdrawn | N/A | 0 | Carevive Systems, Inc.INDUSTRY | 0 | Jan 31, 2019 | clinicaltrials |
| NCT03238703 | Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer | withdrawn | Phase 4 | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 27, 2018 | clinicaltrials |
| NCT03388814 | Speeding Recovery From Pain and Opioid Use | withdrawn | Early Phase 1 | 0 | Wake Forest University Health SciencesOTHER | 0 | Nov 30, 2018 | clinicaltrials |
| NCT02470819 | Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer | withdrawn | N/A | 0 | Avera McKennan Hospital & University Health CenterOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| NCT03616457 | Automated Breast Ultrasound as an Adjunct to Screening Digital Breast Tomosynthesis(AMELIA) | withdrawn | — | 0 | GE HealthcareINDUSTRY | 0 | Oct 26, 2018 | clinicaltrials |
| NCT02988648 | A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter | withdrawn | Phase 1 / Phase 2 | 0 | Yale UniversityOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT03285607 | MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Aug 16, 2018 | clinicaltrials |
| NCT03326258 | Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery | withdrawn | Phase 1 / Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Jul 18, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Jul 31, 2020source: clinicaltrials